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Murine hepatitis virus strain 3 (MHV-3) produces a strain-dependent pattern of disease which has been
used as a model for fulminant viral hepatitis. This study was undertaken to examine whether there was a
correlation between macrophage activation and susceptibility or resistance to MHV-3 infection. Peritoneal
macrophages were isolated from resistant A/J and susceptible BALB/cJ mice and, following stimulation with
MHV-3 or lipopolysaccharide (LPS), analyzed for transcription of mRNA and production of interleukin-1
(IL-1), tumor necrosis factor alpha (TNF-a), transforming growth factor b (TGF-b), mouse fibrinogen-like
protein (musfiblp), tissue factor (TF), leukotriene B4, and prostaglandin E2 (PGE2). Macrophages from
BALB/cJ mice produced greater amounts of IL-1, TNF-a, TGF-b, leukotriene B4, and musfiblp following
MHV-3 infection than macrophages from resistant A/J mice, whereas in response to LPS, equivalent amounts
of IL-1, TNF-a, TGF-b, and TF were produced by macrophages from both strains of mice. Levels of mRNA of
IL-1, TNF-a, and musfiblp were greater and more persistent in BALB/cJ than in A/J macrophages, whereas the
levels and kinetics of IL-1, TNF-a, and TF mRNA following LPS stimulation were identical in macrophages
from both strains of mice. Levels of production of PGE2 by MHV-3-stimulated macrophages from resistant and
susceptible mice were equivalent; however, the time course for induction of PGE2 differed, but the total quantity
of PGE2 produced was insufficient to inhibit induction of musfiblp, a procoagulant known to correlate with
development of fulminant hepatic necrosis in susceptible mice. These results demonstrate marked differences
in production of inflammatory mediators to MHV-3 infection in macrophages from resistant A/J and suscep-
tible BALB/cJ mice, which may explain the marked hepatic necrosis and fibrin deposition and account for the
lethality of MHV-3 in susceptible mice.
An incomplete understanding of the pathogenesis of fulmi-
nant viral hepatitis has limited the development of successful
medical approaches to its treatment (35, 46). Recent studies
using a model of hepatitis induced by infection with murine
hepatitis virus strain 3 (MHV-3) have provided significant in-
sight into the mechanisms underlying this disease process (13,
19, 33). One of the unique features of MHV-3-induced fulmi-
nant hepatitis is its strain-dependent pattern of disease. While
low doses of MHV-3 cause hepatocellular necrosis and death
in susceptible BALB/cJ mice, A/J mice are totally resistant and
semisusceptible C3H mice develop acute hepatitis which
progresses to chronic hepatitis (36).
MHV-3-induced fulminant hepatitis is characterized patho-
logically by sinusoidal thrombosis and associated hepatocellu-
lar necrosis (17, 36, 42). Several lines of evidence suggest that
stimulation of the immune coagulation system by MHV-3 par-
ticipates in the disease process. First, induction of monocyte/
macrophage procoagulant activity (PCA) correlates well with
the severity of the disease during infection (18, 36). Second,
administration of exogenous prostaglandin E2 (PGE2) com-
pletely inhibits induction of PCA and prevents the develop-
ment of hepatic necrosis (1, 55). Finally, treatment of mice
with a monoclonal antibody to the MHV-3-induced PCA pre-
vents the lethality associated with MHV-3 infection (22, 37).
Considered together, these studies suggest a causal relation-
ship between macrophage activation, subsequent fibrin depo-
sition through the production of PCA, and the pathogenesis of
the disease. We have now identified the MHV-3-induced PCA
as mouse fibrinogen-like protein (musfiblp), a protease with
direct prothrombin cleaving activity (13, 30, 49). This molecule
is distinct from the lipopolysaccharide (LPS)-induced macro-
phage procoagulant tissue factor (TF), the cellular receptor
and essential cofactor for the serine protease factor VII (40).
In several other animal models of liver injury, including
those due to CCl4, endotoxin, galactosamine, and acetamino-
phen, the hepatic injury is associated with fibrin deposition,
sinusoidal thrombosis, and accumulation of inflammatory cells
(3, 24, 34, 60). In the hepatocellular necrosis associated with
these pathologic processes, resident macrophages within the
liver (Kupffer cells) exhibit morphologic features of activation
and release a number of inflammatory mediators, including
tumor necrosis factor (TNF), interleukin-1 (IL-1), proteolytic
enzymes, and eicosanoids, as well as superoxide anions and
nitric oxide (34). In liver necrosis induced by Corynebacterium
parvum and endotoxin, a correlation has been demonstrated
between the amount of liver injury and serum levels of lipid
peroxidation products (4), while pretreatment with superoxide
dismutase reduces the extent of the liver damage and mortality
(3). Furthermore, liver injury associated with alcohol and en-
dotoxin correlates with macrophage production of eicosanoids
and TNF-a (43).
Macrophages are known to generate a wide range of medi-
ator molecules which may contribute either directly or indi-
rectly to the development of fulminant hepatitis by inducing
PCA (60). TNF and IL-1 production by macrophages can stim-
ulate endothelial cell TF production and increase neutrophil-
endothelial interactions, thereby potentially promoting micro-
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vascular thrombosis (7, 48, 57). Leukotriene B4 (LTB4),
another macrophage product, has also been shown to contrib-
ute to hepatocellular necrosis (54).
Given the importance of the macrophage in the pathogen-
esis of hepatic necrosis following MHV-3 infection, this study
was carried out to determine whether differences in the pro-
duction of the procoagulants TF and musfiblp, the proinflam-
matory mediators TNF, LTB4, and IL-1, and the anti-inflam-
matory mediators transforming growth factor b (TGF-b) and
PGE2 in macrophages from resistant and susceptible strains of
mice could account for the different patterns of disease seen
following MHV-3 infection in vivo.
MATERIALS AND METHODS
Mice. Female BALB/cJ and A/J mice, 6 to 8 weeks of age, were purchased
from Jackson Laboratory (Bar Harbor, Maine) and were stored in the animal
colony at the University of Toronto. They were fed a standard chow diet and
water ad libitum prior to and during the studies.
Virus. MHV-3 was plaque purified on monolayers of DBT cells. It was grown
to a titer of 1.5 3 107 PFU/ml in 17 CL1 cells. Viral titers were determined on
monolayers of L2 cells in a standard plaque assay as previously described (36).
Peritoneal macrophages. Peritoneal macrophages were harvested from A/J
and BALB/cJ mice 4 days after intraperitoneal administration of 1.5 ml of 3%
thioglycolate (Difco Laboratories, Detroit, Mich.) as previously described (37).
After being washed, the macrophages were resuspended at 106/ml in RPMI 1640
(ICN Biomedicals Inc., Costa Mesa, Calif.) supplemented with 2 mM glutamine
(Sigma Chemical Co., St. Louis, Mo.) and 2% heat-inactivated fetal calf serum
(Flow Laboratories, Mississauga, Ontario, Canada). Cell suspensions contained
greater than 95% macrophages as determined by morphology, nonspecific es-
terase staining, and staining with antibody MAC-1 (22). Viability exceeded 98%
by trypan blue exclusion.
PCA. Macrophages were evaluated for functional PCA in a one-stage clotting
assay as previously described (36). Following incubation, samples to be assayed
for PCA were washed three times with unsupplemented RPMI 1640 and then
resuspended in unsupplemented RPMI 1640 at a concentration of 106/ml. The
cells were then subjected to three cycles of freeze-thawing to obtain maximal
total cellular PCA (36). Samples were assayed for the ability to shorten the
spontaneous clotting time of normal citrated human platelet-poor plasma. Ad-
ditional studies were performed with human plasmas which were congenitally
deficient in coagulation factor VII, X, or II or fibrinogen (Helena Laboratories,
Beaumont, Tex.) to determine the nature (factor dependence) of the procoagu-
lant (36). Milliunits of PCA were assigned by reference to a standard curve
generated with serial log dilutions of a standard rabbit brain thromboplastin
(Dade Division, American Hospital Supply Co., Miami, Fla.). Media and re-
agents were without activity.
TNF. TNF activity was detected by using a semiautomated L929 fibroblast
modified lytic assay as described by Kunkel et al. (32). The amount of cell lysis
was determined by using a micro enzyme-linked immunosorbent assay auto-
reader. Units of TNF activity were determined by comparison with the amount
of lysis generated by serial dilutions of recombinant TNF (Zanzyme, Boston,
Mass.).
IL-1. Induction of IL-1 by MHV-3 in macrophages recovered from A/J or
BALB/cJ mice was assessed by using the mouse thymocyte proliferation assay
(45). Briefly, 106 C3H/HeJ mouse thymocytes were cultured in a final volume of
200 ml in RPMI 1640 supplemented with 10% fetal calf serum, 4 mM glutamine,
5 3 1025 M mercaptoethanol (Sigma), and 100 U of penicillin and 100 mg of
streptomycin (Flow Laboratories) per ml in 96-well flat-bottom microtest plates
(Falcon Laboratories, Grand Island, N.Y.) with dilutions of UV-inactivated
macrophage supernatants in the absence or presence of concanavalin A (2.5
mg/ml). Cultures were incubated for 66 h in a humidified CO2 atmosphere at
378C, pulsed with 1 mCi of [3H]thymidine (specific activity, 2 Ci/mmol; New
England Nuclear, Boston, Mass.), and harvested at 72 h onto glass fiber filters.
Total cell-associated radioactivity was measured in a Beckman scintillation
counter, and bioassay data are expressed as units per milliliter, derived from a
standard curve with mouse recombinant IL-1b (Genzyme, Boston, Mass.). Rab-
bit anti-mouse IL-1b antibodies (Genzyme) neutralized greater than 92% of
experimental IL-1 activity, whereas rabbit anti-mouse IL-6 antibodies (Gen-
zyme) had no effect on IL-1 activity.
LTB4. LTB4 was determined in a competitive inhibition radioimmunoassay
(RIA) (New England Nuclear) (51). Rabbit anti-LTB4 serum was diluted 1:1,000
in RIA buffer (50 mM Tris [pH 8.6] containing 0.1% gelatin), and aliquots (0.1
ml) were mixed with standard or sample (0.1 or 0.2 ml) in glass tubes (10 by 75
mm). 3H-LTB4 (specific activity, 30 Ci/mmol) in RIA buffer (0.1 ml containing
approximately 7,500 dpm) was added to give a total incubation volume of 0.4 ml,
and the mixture was incubated at 48C for 18 to 24 h. Free LTB4 was adsorbed
onto dextran-coated charcoal as described for RIA of 6-keto-prostaglandin F1a
(15); after centrifugation, the supernatant containing the antibody-antigen com-
plex was collected, and the radioactivity was determined in a liquid scintillation
counter. Although maximum binding of 3H-LTB4 to the antiserum occurred
after 1 h of incubation at 0 to 48C, the incubation was continued overnight to
ensure a consistent equilibrium between free acid and lactone in standards and
sample. Buffer at pH 8.6 rather than 7.4 was used to minimize lactonization of
LTB4. Specificity of the RIA was determined by measuring the inhibition of
3H-LTB4 binding to the antiserum by a series of related hydroxy acids and
prostaglandins; relative cross-reactions were calculated from the mass of the
compound which caused 50% inhibition of binding.
The reproducibility of the assay was determined by repeated measurement of
standard solutions of LTB4 and samples containing LTB4.
TGF-b. Levels of TGF-b were determined by measuring the inhibition of
growth of the TGF-b-sensitive mink lung epithelial cell line Mv1Lu (CCL-64;
American Type Culture Collection, Rockville, Md.) (14). Briefly, mink lung
epithelial cells were maintained in Eagle’s minimum essential medium (Gibco
Laboratories, Grand Island, N.Y.) supplemented with 4 mM glutamine, 1.5 mM
N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid (HEPES), and 10% fetal
calf serum. Then 5 3 104 cells were plated in 200 ml of medium in 96-well plates
(Corning Glass Works, Corning, N.Y.) and incubated for 20 h at 378C in a 5%
CO2 atmosphere. After 20 h, the cells were washed and resuspended in 100 ml of
medium and 100 ml of UV-inactivated supernatants from peritoneal macro-
phages from A/J or BALB/cJ mice which had been incubated in the presence or
absence of MHV-3 for up to 24 h. Prior to addition to the culture wells, the
supernatants were heated at 758C for 5 min to inactivate the latent TGF-b
present in the supernatant (9). The cells were then pulse labeled with [3H]thy-
midine (1.0 mCi per well; Amersham, Mississauga, Ontario, Canada) and incu-
bated for an additional 8 h. Cells were then harvested onto glass fiber filters, and
[3H]thymidine incorporation was measured in an LKB-Wallac liquid scintillation
counter. Growth inhibition was measured by the incorporation of [3H]thymidine
and converted to nanograms of TGF-b per milliliter by comparison with a
standard curve constructed by using recombinant human TGF-b (R and D
Systems, Minneapolis, Minn.). Supernatants were devoid of replicating virus as
determined by plaque assay (36). UV-inactivated MHV-3 (108 viral particles per
ml) had no effect on the growth of the Mv1Lu cell line.
PGE2. Supernatants from control and MHV-3-infected macrophages in cul-
ture were collected and assayed for PGE2 by RIA (New England Nuclear) (32).
Tubes were counted in a gamma counter with an efficiency of 44% for 1 min.
Average counts were determined for a set of duplicates, and the normalized
percent bound (% B/B0) for each standard and sample was determined as [(net
cpm of sample/standard)/net cpm of standard] 3 100.
Northern (RNA) blot analysis. The levels of mRNA transcripts of TF, mus-
fiblp (prothrombinase), TNF, and IL-1 were assayed by Northern blot analysis.
Macrophages were pelleted in 15-ml polypropylene tubes (Falcon; Becton Dick-
inson Labware, Lincoln Park, N.J.), and total cellular RNA was isolated by 8 M
acid-guanidium hydrochloride extraction in a modified procedure described by
Arnstein and Cox (2) or by cesium chloride ultracentrifugation (25). RNA was
resolved on a 1% agarose gel containing formaldehyde and transferred onto a
nitrocellulose membrane (Bio-Rad, Oakville, Ontario, Canada). A 1-kb tissue
factor cDNA (50), a 1.3-kb musfiblp cDNA (49), a 1.4-kb TNF cDNA (10), and
a 2-kb IL-1 cDNA (38) were excised from plasmids and purified by agarose gel
electrophoresis. The probes were labeled by using a random-priming DNA
labeling system (Pharmacia Inc., Montreal, Quebec, Canada) with [a-32P]dCTP
(specific activity, .3,000 Ci/mmol; Amersham).
Membranes were prehybridized for 5 h at 428C in a mixture containing form-
amide (50%), 53 Denhardt’s solution, 0.2% sodium dodecyl sulfate, 100 mg of
denatured salmon sperm DNA per ml, and 53 SSPE (13 SSPE is 0.18 M NaCl,
10 mM NaH2PO4, and 1 mM EDTA [pH 7.7]) buffer. Hybridization was carried
out overnight at 428C in the same mixture. The membranes were then washed
under low- to medium-stringency conditions, and the membranes were exposed
to Kodak XAR-5 film with intensifying screens for 24 h at 2708C. To confirm
that equivalent amounts of RNA had been added in all lanes, the membrane was
probed with an a-tubulin cDNA.
Endotoxin contamination. Media were tested for endotoxin contamination by
the standard Limulus amoebocyte lysate assay (Association of Cape Cod, Woods
Hole, Mass.) and were found to contain less than 0.003 ng of endotoxin per ml,
which constituted the lower limit of the test.
Statistical analysis. Statistical analysis was carried out by using analysis of
variance and the Wilcoxon rank sum test, and a P value of 0.05 or less was
considered to be statistically significant. Results are reported as the mean and
standard deviation for at least four separate experiments, each performed in
triplicate.
RESULTS
Viral titers. The patterns of viral growth as determined by
measurement of sequential viral titers were similar in macro-
phages from resistant A/J and susceptible BALB/cJ mice as
described previously (42).
PCA. The time course for induction of functional PCA by
MHV-3 in peritoneal macrophages isolated from BALB/cJ and
A/J mice is shown in Fig. 1A. Macrophages from susceptible
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mice infected with MHV-3 demonstrated a significant rise in
PCA as early as 4 h postinfection (p.i.) (645 6 140 mU/106
macrophages), reaching a maximum level of 7,480 6 840 mU/
106 macrophages at 18 h p.i., in comparison with basal values
of 120 6 30 mU/106 macrophages in unstimulated controls.
Induction of PCA by MHV-3 in macrophages from BALB/cJ
mice was dose dependent, with induction of 9206 140 mU/106
macrophages seen following stimulation with 10 PFU and
reaching a maximum of 52,400 6 16,500 mU/106 macrophages
with 107 PFU of MHV-3 (Fig. 1B). No induction of PCA above
the basal activity of 1206 25 mU/106 macrophages was seen in
macrophages from resistant A/J mice at all titers of virus used
(10 to 107 PFU) and at all time points studied (0 to 48 h) (Fig.
1A and B).
Data shown in Table 1 demonstrate that MHV-3-induced
PCA was independent of factors VII and X but dependent on
factor II, consistent with previous studies characterizing the
MHV-3-induced PCA as a prothrombinase (13, 22, 36). In
contrast to cells stimulated with MHV-3, LPS induced a rapid
and equivalent rise in PCA in peritoneal macrophages from
both A/J and BALB/cJ, an activity which was evident at 1 to 2
h and reached a maximum at 8 to 12 h (Fig. 1C). Studies using
factor-deficient plasma indicated that the nature of the LPS-
induced PCA was consistent with that of TF (Table 1). LPS-
stimulated cells were incapable of initiating coagulation of
factor VII-deficient plasma, indicating that no prothrombinase
activity was induced by LPS.
Northern blot analyses were performed with the cDNA
probes for TF and musfiblp. RNA hybridizing to the musfiblp-
specific probe was not detected in RNA isolated from unin-
fected macrophages from either A/J or BALB/cJ mice. In
MHV-3-infected macrophages from BALB/cJ mice, musfiblp-
specific mRNA was first detected at 2 h, peaked at 8 h, and was
still detectable at 12 h p.i. (data not shown). The kinetics of
induction of musfiblp mRNA was similar to that previously
reported (49). Transcription of musfiblp RNA was also ob-
served in A/J macrophages which had been infected with
MHV-3; however, the level of maximum induction occurred
later (12 h p.i.) and was 35-fold less than that observed in
BALB/cJ macrophages (data not shown), similar to previously
reported results (49). RNA isolated from A/J and BALB/cJ
macrophages which had been stimulated with LPS did not
hybridize with musfiblp but hybridized with the TF cDNA
probe (data not shown).
TNF. The production of TNF by peritoneal macrophages
from BALB/cJ and A/J mice stimulated with 10 mg of LPS per
ml is depicted in Fig. 2A. Low basal levels of TNF were de-
tected in macrophages from both BALB/cJ (206 10 U/ml) and
A/J (25 6 15 U/ml) mice (Fig. 2). The pattern of TNF pro-
duction in response to LPS stimulation did not differ between
resistant and susceptible strains. TNF production in macro-
phages from BALB/cJ and A/J mice was characterized by early
increases from 20 6 10 and 25 6 15 U/ml, respectively, to 590
6 90 and 485 6 120 U/ml, respectively, at 6 h of incubation.
TNF continued to rise to reach maximum levels of 1,1506 105
and 1,100 6 200 U/ml, respectively, at 24 h (Fig. 2A).
Induction of TNF in macrophages from resistant and sus-
FIG. 1. Induction of PCA in macrophages from A/J and BALB/cJ mice by
MHV-3 and LPS. (A) One million macrophages from A/J (n) or BALB/cJ ()
mice were stimulated with MHV-3 at an MOI of 0.1. Cells were harvested at
times shown, and following freeze-thawing, maximal cellular PCA was measured.
(B) One million macrophages were stimulated with various doses of MHV-3 and
harvested after 18 h for measurement of PCA activity. (C) Macrophages were
stimulated with 10 mg of LPS per ml and assayed for total content of PCA.
Results represent the mean 6 standard deviation of three separate experiments
done in duplicate. (p indicates P , 0.05 compared with control unstimulated
cells.)
TABLE 1. Effect of coagulation factor-deficient plasmas
on PCA expressiona
Plasma
PCA (mU/106 cells)
LPS MHV-3
Normal 740 6 145 7,480 6 840
Deficient in:
Factor VII ,10 7,530 6 620
Factor X ,1 7,160 6 510
Factor II ,1 ,10
Fibrinogen ,1 ,1
a One million BALB/c macrophages were stimulated with LPS (10 mg/ml) or
MHV-3 (MOI of 0.1) for 18 h, harvested, and assayed for the ability to shorten
the spontaneous clotting time of recalcified normal platelet-poor citrated human
plasma or human plasmas deficient in factor II, VII, or X or fibrinogen in a
one-stage clotting assay. Results represent the mean 6 1 standard deviation for
three separate experiments.
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ceptible mice in response to stimulation with 105 PFU of
MHV-3 is plotted against time in Fig. 2B. A marked increase
in TNF was observed in BALB/cJ macrophages, with a maxi-
mum response of 9,800 6 2,200 U/ml observed at 24 h p.i. The
level of TNF induction achieved in A/J macrophages was less
than that seen in BALB/cJ macrophages and remained con-
stant from 12 to 24 h p.i. rather than continuing to increase as
was seen in macrophages from BALB/cJ mice.
By Northern blot analysis, LPS induced an equivalent in-
crease in mRNA from both resistant A/J and susceptible
BALB/cJ macrophages by 2 h which could still be detected at
8 h (Fig. 3A). Following MHV-3 infection, maximal TNF
mRNA levels in macrophages from A/J mice were detected at
2 h, falling thereafter but being still detectable at 8 h. In
contrast, in macrophages from BALB/cJ mice, TNF mRNA
was detected in small amounts at 2 h, but continued to increase
up to 12 h p.i. (Fig. 3B).
IL-1. Supernatants from macrophages were analyzed for
production of IL-1 in response to both LPS (10 mg/ml) (Fig.
4A) and MHV-3 (Fig. 4B). In response to LPS, nearly equiv-
alent increases in the production of IL-1 were detected in
macrophages from A/J and BALB/cJ mice (P. 0.15 at all time
points). An increase in IL-1 was detected at 2 h following
stimulation with LPS, reaching maximum levels by 4 h and then
slowly declining to near baseline levels by 24 h (Fig. 4A).
Following stimulation with 105 PFU of MHV-3, equivalent
IL-1 responses were seen in macrophages from BALB/cJ and
A/J mice at 4 h p.i., but by 8 h and at all time points thereafter
to 24 h, the production of IL-1 by BALB/cJ macrophages in
response to MHV-3 stimulation was greater than that seen in
macrophages from A/J mice. For both strains of mice, IL-1
production in response to MHV-3 was less than that in re-
sponse to LPS (P , 0.005) (Fig. 4B). By Northern analysis, in
response to LPS, mRNA was detected at 2 h in both BALB/cJ
and A/J macrophages and persisted to 8 h (Fig. 5A). In re-
sponse to MHV-3, mRNA levels were less than those induced
by LPS but could be detected by 2 h and persisted for 12 h in
macrophages from BALB/cJ mice, whereas in A/J macro-
phages, IL-1 mRNA peaked at 2 h and thereafter diminished,
correlating with functional IL-1 activity (Fig. 5B).
LTB4. The time course for the production of LTB4 in
BALB/cJ and A/J macrophages in response to LPS is shown in
Fig. 6A. A steady time-dependent increase in LTB4 was ob-
served in macrophages from susceptible mice, attaining a max-
imum observed value at 24 h poststimulation (13.2 6 1.4 pg/
ml). In contrast, no increase in LTB4 was seen in macrophages
from resistant mice at any time point studied to 24 h.
The time course for the induction of LTB4 in peritoneal
macrophages in BALB/cJ and A/J macrophages infected with
MHV-3 is shown in Fig. 6B. A steady increase in LTB4 was
noted in macrophages from susceptible BALB/cJ mice, with
peak levels at 24 h (25.2 6 2.4 pg/ml). Similar to the lack of
response to LPS, no significant production of LTB4 above the
basal level of 1.5 6 1.0 pg/ml was demonstrated in A/J mac-
rophages following MHV-3 infection.
Induction of immunosuppressive molecules by MHV-3. (i)
TGF-b. TGF-b is a multifunctional modulator of cell activity
(56). It has a broad spectrum of action on several cell types and
is known to be a powerful inhibitor of cell proliferation and cell
function (29). Within the immune system, TGF-b functions
FIG. 2. Induction of TNF by LPS (A) and MHV-3 (B). One million macro-
phages from A/J or BALB/cJ macrophages were stimulated with MHV-3 at an
MOI of 0.1 or LPS at 10 mg/ml. TNF levels in the supernatants were measured
by an L929 fibroblast modified lytic assay after incubation for the times shown.
Results represent the mean 6 standard deviation for three separate experiments
done in triplicate. (p indicates P , 0.05 compared with stimulated A/J macro-
phages.)
FIG. 3. TNF-a mRNA levels in BALB/c and A/J macrophages stimulated
with MHV-3 or LPS. Ten micrograms of total RNA isolated from peritoneal
macrophages from BALB/cJ and A/J macrophages which had been stimulated
with 10 mg of LPS per ml (A) or 105 PFU of MHV-3 (B) for periods of time up
to 12 h was added to each lane, and the RNA was hybridized with a TNF-a
cDNA as described in Materials and Methods. An a-tubulin cDNA was used to
ensure equal levels of mRNA in all lanes (data not shown).
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primarily as an immunosuppressive cytokine inhibiting both
cellular and humoral immunity (29). We therefore studied
whether increased production of this cytokine might account
for the lack of responsiveness to MHV-3 infection. Macro-
phages from resistant (A/J) and susceptible (BALB/cJ) mice
produced comparable amounts of TGF-b in response to LPS
stimulation over a 24-h period (Fig. 7A). An increase in TGF-b
could be detected within 1 h of stimulation, reaching maximal
levels at 18 h and decreasing by 24 h. Following MHV-3 in-
fection, TGF-b could be detected in macrophages from
BALB/cJ mice within 1 h of infection, reaching maximal levels
by 6 h and declining to 50% of peak values over the next 18 h
(Fig. 7B). The TGF-b response to MHV-3 was greater than the
response to LPS at all time points. In contrast, macrophages
from A/J mice failed to produce TGF-b above basal levels in
response to MHV-3 at all time points studied to 24 h (Fig. 7B).
(ii) PGE2. PGE2 is an immunosuppressive prostanoid known
to downregulate the production of a variety of inflammatory
molecules, including TNF and IL-1, and PCA (55). We there-
fore tested the hypothesis that an increased production of this
molecule in A/J mice might be responsible for the lack of
response of macrophages from these mice to MHV-3.
The time course for induction of PGE2 production following
MHV-3 infection was more rapid in macrophages from resis-
tant A/J mice than in those from susceptible BALB/cJ mice (1
h versus 2 h), and at 2 h p.i., the amount produced was greater
(5 3 10213 M compared with 1 3 10213 M; P , 0.03) (Fig.
8A). However, by 6 h p.i., there were no significant differences
in PGE2 production although maximum levels of PGE2 pro-
duction by macrophages from BALB/cJ mice (10212 M) oc-
FIG. 4. Induction of IL-1 by LPS and MHV-3. One million macrophages
from A/J or BALB/cJ mice were stimulated with LPS at 10 mg/ml (A) or MHV-3
at an MOI of 0.1 (B) for the times shown. IL-1 was measured in the supernatants
by a thymocyte proliferation assay. Results represent the mean 6 standard
deviation for three separate experiments done in triplicate. (p indicates P , 0.05
compared with stimulated A/J macrophages.)
FIG. 5. IL-1-amRNA expression in macrophages stimulated with MHV-3 or
LPS. Ten micrograms of total RNA extracted from BALB/cJ and A/J macro-
phages which had been stimulated with 10 mg of LPS per ml (A) or 105 PFU of
MHV-3 (B) was added to each lane and hybridized with an IL-1-a cDNA as
described in Materials and Methods. An a-tubulin cDNA was used to ensure
equal loading of all lanes (data not shown).
FIG. 6. Induction of LTB4 by LPS and MHV-3. One million macrophages
from A/J or BALB/cJ mice were stimulated with LPS at 10 mg/ml (A) or MHV-3
at an MOI of 0.1 (B) for the times (in hours) shown. LTB4 was measured in the
supernatants by a competitive inhibition RIA as described in Materials and
Methods. Results represent the mean 6 standard deviation for three separate
experiments done in triplicate. (p indicates P , 0.05 compared with stimulated
A/J macrophages.)
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curred later than in macrophages from A/J mice (12 h versus 6
h).
To determine whether endogenously produced PGE2 was
capable of modulating induction of PCA by MHV-3-stimu-
lated macrophages from BALB/cJ or A/J mice, indomethacin
(50 mg/ml) was added during stimulation of macrophages with
MHV-3. This concentration had previously been shown to
inhibit PGE2 release (data not shown). Figure 8B shows that
indomethacin was unable to restore PCA production by mac-
rophages from A/J mice infected with MHV-3, nor did it alter
PCA production by MHV-3-stimulated macrophages from
BALB/cJ mice.
DISCUSSION
Although the mechanism of susceptibility and resistance to
MHV-3 is poorly understood, previous work has implicated the
macrophage as a contributor to resistance to MHV-3 (5, 23,
53). Initial studies have suggested that differences in the rate of
MHV replication in macrophages from resistant and suscepti-
ble animals accounted for host resistance or susceptibility (5,
23). However, subsequent work has failed to reproduce these
differences in patterns of viral replication (31, 41). In the
present study, there were no significant differences in viral
replication in macrophages from resistant and susceptible an-
imals, supporting the concept that additional factors may be
involved in the differential response of these mice to infection
with MHV-3.
MHV-3 stimulation of macrophages from susceptible
BALB/cJ mice resulted in a rapid production of IL-1, TNF,
TGF-b, LTB4, and the procoagulant musfiblp, whereas mac-
rophages from resistant A/J mice either did not produce these
mediators or produced them in lesser amounts and for a
shorter duration. Although a multiplicity of infection (MOI) of
0.1 was used for most experiments shown, similar results were
obtained with an MOI of 10 (not shown). Thus, we believe that
the inflammatory mediators detected following MHV-3 infec-
tion of macrophages originate from infected cells, although
activation of adjacent uninfected macrophages cannot be ex-
cluded. The observation that macrophages from A/J mice were
able to produce IL-1, TNF, and TGF-b in response to LPS
implies that the differences in signaling must be specific to
MHV-3 rather than a global nonresponsiveness of these mac-
rophages. It is unclear why A/J macrophages did not produce
LTB4 in response to either LPS or MHV-3. Possible explana-
tions include inhibition of 5-lipoxygenase activity through a yet
unclear mechanism or a defect in the production of a mem-
brane protein termed the 5-lipoxygenase-activating protein,
which is required for LTB4 synthesis in response to ionophore
stimulation (20, 44).
Kinetic differences in the production and subsequent down-
regulation of inflammatory mediator levels in response to
MHV-3 were observed. The differences may be due to (i)
differences in induction of mRNA transcription in macro-
phages from susceptible and resistant mice, which may in turn
be related to differences in signal transduction or to mediator
interactions; (ii) differential impairment of host cell mRNA
FIG. 7. Induction of TGF-b by LPS and MHV-3. One million A/J or
BALB/cJ macrophages were stimulated with LPS at 10 mg/ml (A) or MHV-3 at
an MOI of 0.1 (B) for the times shown. TGF-b was measured in the supernatants
by the inhibition of the growth of the mink lung epithelial cell line Mv1Lu.
Results represent the mean 6 standard deviation for three experiments. (p
indicates P , 0.05 when compared with stimulated A/J macrophages.)
FIG. 8. (A) Production of PGE2 following MHV-3 stimulation. One million
A/J or BALB/cJ macrophages were stimulated with MHV-3 at an MOI of 0.1 for
the times shown, and PGE2 levels in the supernatants were measured by RIA.
Results represent the mean 6 standard deviation for three separate experiments
done in triplicate. (p indicates P , 0.05.) (B) Effect of indomethacin on MHV-
3-stimulated PCA production. One million A/J or BALB/cJ macrophages were
preincubated in medium with or without indomethacin at a concentration of 50
mg/ml for 1 h and then stimulated with MHV-3 at an MOI of 0.1. The cells were
harvested after the times shown, and PCA was measured in a one-stage clotting
assay as described in Materials and Methods. Results represent the mean 6
standard deviation for three separate experiments done in duplicate.
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translation by MHV-3 (27); and (iii) differential rates of deg-
radation of mRNA and functional protein.
Evaluation of the mRNA transcripts for musfiblp indicated
that the levels paralleled the expression of PCA activity in A/J
and BALB/cJ mice. Three different musfiblp-specific RNA
species were detected in MHV-3-infected macrophages, with
the predominant species being approximately 4 kb in length.
Small amounts of larger RNAs, approximately 6.5 and 7.5 kb in
length, were also observed. The 4-kb RNA corresponds in size
to transcripts of musfiblp originally described in cytotoxic T
lymphocytes and is thought to represent a fully spliced mature
mRNA (30). The less abundant larger RNA species may cor-
respond to either unspliced or alternatively spliced transcripts
or possibly polyadenylation at an alternative downstream poly-
adenylation site. The maximum level and duration of expres-
sion of the predominant 4-kb mRNA transcripts from the
macrophages from BALB/cJ mice was significantly greater
than those observed in macrophages from A/J mice, suggesting
differences in the signaling pathways in response to MHV-3 in
A/J mice compared with BALB/cJ mice. Alternatively, the
differences in the level of transcripts may be related to different
degrees of mRNA stability in the two strains. Hilton et al. (27)
have reported that MHV infection of fibroblasts may destabi-
lize at least some host mRNAs at late times of infection; this
effect could contribute to the decline of musfiblp mRNAs that
we observe 12 h p.i. However, no functional PCA was pro-
duced in A/J mouse-derived macrophages. Previous studies
with a monoclonal antibody against the prothrombinase
(3D4.3) have also failed to demonstrate PCA expression in
MHV-3-stimulated A/J macrophages (22), suggesting that the
musfiblp transcripts detected in A/J macrophages are either
not translated or not properly modified posttranslation. Our
previous observation that PGE2 reduces functional PCA in
MHV-3-stimulated BALB/cJ macrophages by a posttranscrip-
tional mechanism supports the notion that protein modifica-
tion is required for expression of PCA (12). When considered
together, these findings suggest that differences in signaling as
well as possibly transcription, translation, and posttranslational
modification may contribute to the marked differences in mus-
fiblp production to MHV-3 stimulation in resistant and sus-
ceptible mice.
The finding that the nature and pattern of the procoagulants
induced by LPS and MHV-3 were different was not totally
unexpected. First, in previous studies as well as the present
study, analysis using factor-deficient plasmas has consistently
shown that the PCA induced by LPS is dependent on factor
VII for its activity, whereas the MHV-3-induced PCA is de-
pendent only on factor II for its activity (13, 36). Second,
monoclonal antibodies produced against the MHV-3-induced
procoagulant recognize the MHV-3-induced PCA but do not
react with LPS-induced PCA or with human or rabbit throm-
boplastin (37). Third, in this study, Northern analysis using a
murine TF cDNA and a cDNA to musfiblp showed that LPS
stimulation of macrophages from both A/J and BALB/cJ mice
augments the level of transcripts for TF but not musfiblp,
whereas MHV-3 stimulation of macrophages from these same
strains of mice causes transcription of musfiblp and not TF.
Induction of TF in macrophages has also been shown to be
enhanced by CD31 CD41 CD82 TH1 cells (21), whereas we
have recently shown that musfiblp production by macrophages
following MHV-3 infection is inhibited by CD31 CD41 TH1
cells (11). Finally, recent data have demonstrated the presence
of a 56-bp LPS response element within the TF promoter that
confers LPS responsiveness (39). On initial scanning of the 59
promoter region of musfiblp, this sequence is not present,
possibly explaining the inability of LPS to induce musfiblp
transcription.
Differences in transcription of IL-1 and TNF were also ob-
served in MHV-3-stimulated macrophages from A/J and
BALB/cJ mice. IL-1 and TNF mRNA transcription from mac-
rophages from resistant A/J mice was rapid but decreased by 8
h p.i. In contrast, mRNA transcripts in macrophages from
susceptible BALB/cJ mice continued to increase up to 12 h p.i.
This is in distinct contrast to the equivalent time course of
induction of IL-1 and TNF mRNAs by macrophages from both
strains of mice in response to LPS. The apparent inconsisten-
cies between TNF and IL-1 mRNA and protein levels must be
interpreted bearing in mind that protein levels were estimated
by functional bioassays. Furthermore, the regulation of TNF
and IL-1 protein expression is extremely complex and occurs at
the levels of transcription (28, 52), mRNA stability (10), and
translation (6). For functional activity of IL-1b, cleavage of an
inactive precursor by interleukin-converting enzyme is re-
quired (58).
A role for TNF-a in liver injury has been suggested with
respect to the fulminant hepatitis induced by Propionobacte-
rium acnes and galactosamine (47). Both TNF and IL-1 are
known to activate endothelial cells to produce TF (7, 48) and
may thus contribute to sinusoidal thrombosis following
MHV-3 infection by enhancing production of procoagulants by
endothelial cells (17, 37, 42). Furthermore, LTB4 may also
contribute to the development of hepatic necrosis by causing
vascular permeability changes (59) or by directly damaging
hepatocytes as has been described following frog virus 3 infec-
tion (26).
One possible mechanism underlying the differential suscep-
tibility to infection and the differential induction of macro-
phage products might be that A/J mice generate higher levels
of immunosuppressive factors in response to MHV-3 than do
BALB/cJ mice. TGF-b, a known immunosuppressive cytokine,
was found to be produced by macrophages from susceptible
but not resistant mice in response to MHV-3 infection. Al-
though the exact role for TGF-b in MHV-3 infection has not
been determined, recent experiments in our laboratory have
shown that TGF-b primes macrophages from susceptible mice
to express increased amounts of PCA in response to MHV-3
stimulation (unpublished data), and thus TGF-b may be a
contributing factor to the severity of MHV-3-induced hepatic
necrosis. Furthermore, induction of TGF-b by MHV-3 may
account for the lack of immune responsiveness which is a
known consequence of MHV-3 infection in susceptible mice
(16, 19, 33).
Previous studies from our laboratory have shown that exog-
enous administration of PGE2 blocks induction of the MHV-
3-induced macrophage PCA in vitro and in vivo (12) and pre-
vents fulminant hepatic necrosis in vivo (55). However, the
hepatoprotective effects of PGE2 and inhibition of PCA were
observed only at pharmacologic doses (1028 to 1026 M); at less
than 10212 M, no inhibition of PCA or hepatoprotection was
observed. Although in this study, PGE2 was produced earlier
and in greater amount in A/J macrophages, the amount pro-
duced would appear to be insufficient to inhibit induction of
PCA and prevent hepatic necrosis. In addition, the failure of
indomethacin to affect PCA production in response to MHV-3
suggests that the amount of prostaglandin produced does not
regulate macrophage expression of PCA by either an autocrine
or a paracrine effect. Considered together, these data suggest
that A/J mice are not protected from MHV-3 infection or
induction of cytokines by virtue of their ability to generate
increased levels of immunosuppressive factors.
In conclusion, the pattern of immediate response genes to
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MHV-3 infection in macrophages from susceptible BALB/cJ
mice differs markedly from that of the resistant A/J strain.
Furthermore, these particular mediators, or indeed other
genes regulated in a similar fashion, may be responsible for the
synthesis of products that either primarily drive or contribute
to the complex pattern of pathology seen in MHV-3 infection
as we have previously reported.
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